S. Dalac-Rat

发表

Électronthérapie corporelle totale du mycosis fongoïde aux stades précoces : 68 cas Total skin electron beam therapy for early-stage mycosis fungoides : Immediate results and long-term follow-up in 68 patients

T. Petrella, P. Maingon, G. Jeudy, 2009 .

Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study

T. Jouary, C. Robert, B. Dréno, 2021, International journal of cancer.

Long-term immune-related adverse events under PD-1 inhibitors: a multicenter prospective cohort study (MELBASE).

C. Lebbé, B. Dréno, O. Dereure, 2020 .

An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastases.

J. Grob, C. Lebbé, O. Dereure, 2022, European journal of cancer.

Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study)

A. Duhamel, A. Dupuy, N. Basset-Seguin, 2018, EClinicalMedicine.

Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database

C. Lebbé, B. Dréno, A. Dupuy, 2020, European Journal of Dermatology.

Successful switch to dabrafenib after vemurafenib‐induced toxic epidermal necrolysis

T. Petrella, G. Jeudy, Pierre Vabres, 2015, The British journal of dermatology.

Cutaneous lesions in sporadic angiosarcomas of the breast: a misleading presentation

G. Jeudy, C. Chassagne‐Clément, P. Combemale, 2016, European Journal of Dermatology.

[Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices].

T. Jouary, C. Lebbé, A. Dupuy, 2019 .

Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib.

J. Grob, C. Robert, C. Lebbé, 2021, European journal of cancer.

Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database

B. Dréno, S. Dalle, N. Meyer, 2022, European Journal of Dermatology.

Cutaneous vasculitis associated with mycosis fungoides

O. Dereure, N. Ortonne, V. Lacheretz-Szablewski, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Epidemiological study of unknown primary melanoma patients from the French national melanoma database RIC-Mel.

C. Lebbé, B. Dréno, A. Dupuy, 2018 .

Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real‐world French study

M. Bagot, F. Grange, G. Quéreux, 2023, Journal of the European Academy of Dermatology and Venereology.